The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood (Q40012113)

16 September 2017

1 reference

title

The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood (English)

1 reference

16 September 2017

0 references

0 references

Chisolm JJ Jr

1

1 reference

PubMed ID

4969284

16 September 2017

language of work or name

English

0 references

publication date

1 July 1968

1 reference

The Journal of Pediatrics

16 September 2017

1 reference

16 September 2017

73

1 reference

16 September 2017

1

1 reference

16 September 2017

1-38

1 reference

Treatment of lead encephalopathy in children

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

TREATMENT OF LEAD ENCEPHALOPATHY. THE COMBINED USE OF EDETATE AND HEMODIALYSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

ACUTE LEAD ENCEPHALOPATHY IN YOUNG CHILDREN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Aminoaciduria as a manifestation of renal tubular injury in lead intoxication and a comparison with patterns of aminoaciduria seen in other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Penicillamine: the pharmacology of a chelating agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The mobilization and excretion of lead in cattle: a comparative study of various chelating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Chelates as possible contrast media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Toxic side effects of ethylenedia minetetraacetic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Reactions of British anti-lewisite with arsenic and other metals in living systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The use of British anti-lewisite containing radioactive sulphur for metabolism investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Further investigations on the metabolism of 2:3-dimercaptopropanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The action of British anti-lewisite (BAL) on enzyme systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The effect of 2:3-dimercaptopropanol on the activity of enzymes and on the metabolism of tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Influence of Dithiopropanol (BAL) on Human Lead Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Development and theoretical significance of British anti-lewisite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The inhibition of succinoxidase by heavy metals and its reactivation with dithiols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Reactivation by dithiols of enzymes inhibited by lewisite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

British anti-lewisite; dithiol compounds as antidotes for arsenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Penicillamine, a new oral therapy for Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Treatment of lead-poisoning with oral penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Effect of penicillamine on serum iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

THE ANTIPYRIDOXINE EFFECT OF PENICILLAMINE IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Collagen Defect Induced by Penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Accumulation of a collagen precursor in the skin of penicillamine-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Epidermolysis bullosa induced by penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Penicillamine and pyridoxine requirements in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The purification and properties of delta-aminolaevulic acid dehydrase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Preparation and pharmacological properties of 4-hydroxymethyl-2-(3'-amino-4'-hydroxyphenyl)-1:3-dithia-2-arsacyclopentane (Mapharside-BAL compound).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

LEAD POISONING IN CHILDREN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

PEDIATRIC ASPECTS OF THE PORPHYRIAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

In vitro pyrrole and porphyrin synthesis in lead poisoning and iron deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Determination of delta-aminolevulinic acid in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Aminoaciduria in vitamin D deficiency states in premature infants and older infants with rickets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

AMINOACETONE EXCRETION IN PORPHYRIAS AND IN CHRONIC LEAD INTOXICATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Penicillamine as Lead-chelating Substance in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Subsequent mental development of children with lead encephalopathy, as related to type of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Calcium disodium edathamil therapy of lead intoxication. The significance of amino-aciduria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Sustained Action of Injected Chelating Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Edetate kidney lesions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Acute versenate nephrosis; occurring as the result of treatment for lead intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Effects of edathamil disodium on the kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Storage and excretion of lead 210 in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

The sequelae of pica with and without lead poisoning. A comparison of the sequelae five or more years later. I. Clinical and laboratory observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

Quantitative urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2868%2980036-8

10.1016/S0022-3476(68)80036-8

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference

PubMed ID

4969284